A significant unmet need exists for effective, low-toxicity early treatment in IDH-mutant gliomas, especially for younger patients and those with grade 2 tumors. Voranigo, an IDH1 and IDH2 inhibitor, ...
Hosted on MSN
Starting opioid agonist treatment after hospitalization for toxicity halves risk of repeat event
A new study led by researchers at the University of Toronto's Leslie Dan Faculty of Pharmacy and Unity Health Toronto shows that almost one-quarter of hospital-treated opioid toxicities experienced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results